FDA Cites Buenos Aires API Facility for Records, Equipment Calibration

Drug Industry Daily
A A
The FDA rapped Umicore Argentina for violations relating to its control procedures and equipment calibration, following a May inspection of the API manufacturer’s Buenos Aires facility.

To View This Article:

Login

Subscribe To Drug Industry Daily